Cargando…

Application of chromosomal microarray to investigate genetic causes of isolated fetal growth restriction

BACKGROUND: Application of chromosomal microarray analysis (CMA) to investigate the genetic characteristics of fetal growth restriction (FGR) without ultrasonic structural anomalies at 18–32 weeks. METHODS: This study includes singleton fetuses with the estimated fetal weight (EFW) using the formula...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Gang, Lin, Yuan, Xu, Liang Pu, Huang, Hai Long, Liu, Si Ping, Yu, Yan Hong, Yang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987400/ https://www.ncbi.nlm.nih.gov/pubmed/29991965 http://dx.doi.org/10.1186/s13039-018-0382-4

Ejemplares similares

The Genetic Etiology Diagnosis of Fetal Growth Restriction Using Single-Nucleotide Polymorphism-Based Chromosomal Microarray Analysis
por: Chen, Yu'e, et al.
Publicado: (2021)

Fetal genetic findings by chromosomal microarray analysis and karyotyping for fetal growth restriction without structural malformations at a territory referral center: 10-year experience
por: Wu, Xiaoqing, et al.
Publicado: (2023)

Genetic Background of Fetal Growth Restriction
por: Nowakowska, Beata Anna, et al.
Publicado: (2021)

A pilot study on investigating the role of Salvia miltiorrhiza in fetal growth restriction
por: Shen, Fanghua, et al.
Publicado: (2020)

The Genetic and Clinical Outcomes in Fetuses With Isolated Fetal Growth Restriction: A Chinese Single-Center Retrospective Study
por: Zhou, Hang, et al.
Publicado: (2022)

Placental pathology in early-onset fetal growth restriction: insights into fetal growth restriction mechanisms
por: Bujorescu, Daniela-Loredana, et al.
Publicado: (2023)

Chromosome microarray analysis in the investigation of children with congenital heart disease
por: Wu, Xiao-li, et al.
Publicado: (2017)

Chromosomal microarray analysis vs. karyotyping for fetal ventriculomegaly: a meta-analysis
por: Sun, Yan, et al.
Publicado: (2022)

Comparative Diagnostic Performance of Estimated Fetal Weight and Isolated Abdominal Circumference for the Detection of Fetal Growth Restriction
por: Whitham, Megan D., et al.
Publicado: (2022)

Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction
por: Abi Habib, Walid, et al.
Publicado: (2018)

Chromosomal Microarray Analysis as First-Tier Genetic Test for Schizophrenia
por: Chen, Chia-Hsiang, et al.
Publicado: (2021)

Diagnosis and Management of Fetal Growth Restriction
por: Bamfo, Jacqueline E. A. K., et al.
Publicado: (2011)

Sildenafil Citrate in Fetal Growth Restriction
por: Panda, Subrat, et al.
Publicado: (2014)

Early onset fetal growth restriction
por: Dall’Asta, Andrea, et al.
Publicado: (2017)

Placental Metabolomics of Fetal Growth Restriction
por: Troisi, Jacopo, et al.
Publicado: (2023)

Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?
por: Abdalla, Nabil, et al.
Publicado: (2017)

Non-Targeted Metabolomic Study of Fetal Growth Restriction
por: Chen, Fang, et al.
Publicado: (2023)

Prenatal Diagnosis of True Fetal Mosaicism with Small Supernumerary Marker Chromosome Derived from Chromosome 16 by Funipuncture and Molecular Cytogenetics Including Chromosome Microarray
por: Yao, Tien-Yu, et al.
Publicado: (2021)

Fetal growth restriction in a genetic model of sporadic Beckwith–Wiedemann syndrome
por: Tunster, Simon J., et al.
Publicado: (2018)

Investigation of Serum Pregnancy-Specific Beta-1-Glycoprotein and Relationship with Fetal Growth Restriction
por: Tuzluoğlu, Sabiha, et al.
Publicado: (2022)

Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?
por: Karampetsou, Evangelia, et al.
Publicado: (2014)

Performance of Chromosomal Microarray Analysis for Detection of Copy Number Variations in Fetal Echogenic Bowel
por: Fan, Xiangqun, et al.
Publicado: (2021)

Fetal congenital gastrointestinal obstruction: prenatal diagnosis of chromosome microarray analysis and pregnancy outcomes
por: Ni, Mengyao, et al.
Publicado: (2023)

Growth assessment in diagnosis of Fetal Growth Restriction. Review
por: Albu, AR, et al.
Publicado: (2014)

Isolating the role of elevated Phlda2 in asymmetric late fetal growth restriction in mice
por: Tunster, Simon J., et al.
Publicado: (2014)

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
por: Girardi, Guillermina, et al.
Publicado: (2006)

Fetal Growth Restriction Alters Cerebellar Development in Fetal and Neonatal Sheep
por: Yawno, Tamara, et al.
Publicado: (2019)

Pregnancy with Heart Disease: Maternal Outcomes and Risk Factors for Fetal Growth Restriction
por: Nguyen Manh, Thang, et al.
Publicado: (2019)

The importance of fetal gender in intrauterine growth restriction
por: Radulescu, L, et al.
Publicado: (2013)

Maternal sirolimus therapy and fetal growth restriction
por: Tshering, Sangay, et al.
Publicado: (2021)

Fetal Growth Restriction: Comparison of Biometric Parameters
por: Marchand, Carolin, et al.
Publicado: (2022)

Long-term implications of fetal growth restriction
por: D'Agostin, Martina, et al.
Publicado: (2023)

Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restriction
por: Kiyokoba, Ryo, et al.
Publicado: (2022)

Confined placental mosaicism: implications for fetal chromosomal analysis using microarray comparative genomic hybridization
por: Karampetsou, Evangelia, et al.
Publicado: (2014)

Effect of Vitamin D Supplementation on the Fetal Growth Rate in Pregnancy Complicated by Fetal Growth Restriction
por: Jakubiec-Wisniewska, Karolina, et al.
Publicado: (2022)

Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction
por: Tao, Zixin, et al.
Publicado: (2023)

Chromosomal variants accumulate in genomes of the spontaneous aborted fetuses revealed by chromosomal microarray analysis
por: Li, Sen, et al.
Publicado: (2021)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
por: Gong, Sungsam, et al.
Publicado: (2018)

Sildenafil citrate and uteroplacental perfusion in fetal growth restriction
por: Dastjerdi, Marzieh Vahid, et al.
Publicado: (2012)

Sildenafil citrate for the management of fetal growth restriction and oligohydramnios
por: Choudhary, Rana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b0u6eng60hc5bp0tg6hbr43q2c